1. Improvement criteria in drug trials with neurotic patients.
D000654:Amobarbital / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D009497:Neurotic Disorders / Q000188:drug therapy*; D010551:Personality; D010555:Personality Inventory; D010634:Phenobarbital / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D011594:Psychometrics
D002707:Chlordiazepoxide; D008620:Meprobamate; D000654:Amobarbital; D007099:Imipramine; D010634:Phenobarbital